Shinji Toki
9PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 03, 2026
Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.Mark Rusznak, Shinji Toki, Yajing Hao
|Nov 19, 2024
Endogenous Glucagon-Like Peptide-1 Receptor and Glucose-Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen-Induced Innate Airway Inflammation.Shinji Toki, Masako Abney, Jian Zhang
|Dec 14, 2023
Bovine Serum Albumin Elicits IL-33-Dependent Adipose Tissue Eosinophilia: Potential Relevance to Ovalbumin-induced Models of Allergic Disease.Heather L Caslin, W Reid Bolus, Christopher Thomas
|Nov 15, 2022
Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma.Shinji Toki, Jian Zhang, Richard L Printz
|May 06, 2021
Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice.Shinji Toki, Dawn C Newcomb, Richard L Printz
|Jan 25, 2020
TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation.Shinji Toki, Kasia Goleniewska, Jian Zhang
Pageof 2
Frequent Collaborators
5 joint publications
R Stokes Peebles
2 joint publications
Weisong Zhou
1 joint publications
Lauren D Palmer
1 joint publications
Walter J Chazin
1 joint publications
Eric P Skaar
1 joint publications
Hirohito Kita
1 joint publications
Heather L Caslin
1 joint publications
W Reid Bolus
1 joint publications
Allison E Norlander
1 joint publications
Alyssa H Hasty
